Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиAptevo Therapeutics Мультипликаторы 2011-2024 | APVO
Мультипликаторы по годам Aptevo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | 1.2 | -1.3 | -6.1 | -0.6 | -0.6 | 10.4 | -0.4 | - | - | - | - | - |
P/S |
- | 3.1 | 3.0 | 25.1 | 0.8 | 1.4 | 4.9 | 1.1 | - | - | - | - | - |
EPS |
-1.4 | 1.6 | -6.1 | -5.2 | -13.9 | -2.4 | 0.3 | -5.5 | -2.9 | - | - | - | - |
EV (Enterprise Value) |
-2.69 млн | 3.3 млн | 47.2 млн | 105 млн | 54.8 млн | 38.4 млн | 100 млн | 72.7 млн | 19.2 млн | 25.4 млн | - | - | - |
EBITDA per Share |
-2.31 | -5.44 | -4.32 | -8.07 | -13.8 | -30.7 | -33.3 | -36.4 | - | - | - | - | - |
EV/EBITDA |
-2.1 | -2.8 | -0.8 | -0.4 | -1.7 | -0.9 | - | - | - | - | - | ||
PEG |
0.0 | -0.05 | 0.04 | -0.1 | -0.01 | 0.0 | 0.1 | 0.0 | - | - | - | - | - |
P/B |
0.1 | 0.5 | 30.3 | 6.5 | 2.2 | 1.1 | 0.9 | 0.8 | - | - | - | - | - |
P/CF |
-0.1 | -0.5 | -1.7 | -3.7 | -0.6 | -0.6 | -1.7 | -1.0 | - | - | - | - | - |
ROE % |
-142.47 | 44.66 | -2340.21 | -106.97 | -341.56 | -176.57 | 8.50 | -222.31 | - | - | - | - | - |
ROA % |
-70.09 | 23.46 | -50.28 | -33.15 | -75.73 | -79.55 | 5.96 | -122.38 | - | - | - | - | - |
ROCE % |
-236.30 | -159.35 | -1759.87 | -70.48 | -280.81 | -103.57 | -54.77 | -77.35 | - | - | - | - | - |
Current Ratio |
2.0 | 2.1 | 1.0 | 3.3 | 0.8 | 2.8 | 5.1 | 3.7 | - | - | - | - | - |
DSO |
- | - | - | - | 79.0 | 82.6 | 53.3 | 42.9 | - | - | - | - | - |
DIO |
- | - | - | - | 112.4 | 58.1 | 74.9 | 100.2 | - | - | - | - | - |
DPO |
- | - | - | - | 238.9 | 379.9 | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | 191.5 | 140.7 | 128.2 | 143.1 | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | -47.4 | -239.2 | 128.2 | 143.1 | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Aptevo Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.5 | -1.23 | 0.39 | - | -1.5 | 5.58 | -1.55 | - | -1.43 | -1.75 | -1.64 | - | -2.1 | -2.1 | 0.89 | - | -0.16 | -4.14 | -7.64 | - | -0.55 | -0.58 | -0.63 | - | 1.77 | -0.53 | -0.48 | -0.74 | -3.55 | -0.63 | -0.64 | -0.88 | -0.63 | -0.88 | -0.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.08 | - | -1.38 | -1.4 | -1.09 | - | -0.79 | -1.13 | -1.49 | - | -1.6 | -1.87 | -2.19 | - | -3.02 | -3.64 | -6.9 | - | -0.46 | -0.5 | -0.59 | - | -0.34 | -0.61 | -0.54 | -0.72 | -4.33 | -0.55 | -0.6 | - | -0.55 | -0.88 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-128.51 | -133.97 | 36.47 | 203.85 | 107.90 | 60.44 | -118.24 | -222.18 | -263.10 | -208.07 | -191.92 | -64.46 | -122.93 | -140.48 | -212.06 | -272.54 | -313.85 | -296.70 | -227.34 | -130.11 | -83.95 | 3.53 | 33.12 | 20.40 | -9.16 | -197.20 | -208.94 | -222.31 | -212.95 | -85.38 | -79.99 | -54.50 | -34.30 | -19.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-67.03 | -67.80 | 31.89 | 31.04 | 20.11 | 33.29 | -50.00 | -32.58 | -45.27 | -47.02 | -48.62 | -19.98 | -32.94 | -33.22 | -45.48 | -60.43 | -79.04 | -84.69 | -79.20 | -58.61 | -26.25 | 24.73 | 34.64 | 14.30 | -1.97 | -112.43 | -116.85 | -122.38 | -120.12 | -53.29 | -55.07 | -41.04 | -27.03 | -15.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-177.63 | -182.44 | -164.93 | 13.16 | -51.98 | -67.73 | -76.14 | -171.94 | -209.58 | -182.08 | -181.88 | -124.59 | -221.36 | -280.48 | -348.36 | -302.27 | -342.16 | -285.27 | -217.30 | -125.21 | -137.83 | -110.56 | -87.49 | -45.26 | -74.04 | -240.45 | -247.99 | -258.88 | -250.97 | -86.83 | -82.09 | -56.42 | -35.54 | -20.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.2 | 2.3 | 3.0 | 2.1 | 2.0 | 2.5 | 0.9 | 1.0 | 1.1 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.8 | 1.8 | 1.8 | 1.8 | 3.4 | 3.4 | 3.4 | 3.4 | 2.2 | 2.2 | 2.2 | 2.2 | 3.3 | 4.7 | 4.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 77.5 | 81.7 | 71.6 | - | 81.8 | 69.8 | 82.5 | - | 31.6 | 18.1 | 52.1 | 3.2 | 74.4 | 38.4 | 60.7 | 71.1 | 89.8 | 41.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 166.5 | 86.2 | 72.7 | - | 66.8 | 64.3 | 72.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 276.3 | 174.9 | 269.4 | - | 218.5 | 420.3 | 299.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 244.0 | 167.9 | 144.3 | - | 148.6 | 134.1 | 154.6 | - | 31.6 | 18.1 | 52.1 | 3.2 | 74.4 | 38.4 | 60.7 | 71.1 | 89.8 | 41.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -32.4 | -7.0 | -125.1 | - | -69.9 | -286.2 | -144.4 | - | 31.6 | 18.1 | 52.1 | 3.2 | 74.4 | 38.4 | 60.7 | 71.1 | 89.8 | 41.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD